semaglutide bad for kidneys just got FDA-approved kidney disease. This changes everything. January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in type 2 diabetes with CKD. This Semaglutide and Ozempic-like drugs may
Description
Weve uncovered a divide between the way patients perceive GLP-1s as a short-term fix and the clinical science behind how GLP-1s work
Efruxifermin Efruxifermin, a bivalent Fc-FGF21 analog developed by Akero Therapeutics, functions as a balanced agonist of FGFR1c, FGFR2c, and FGFR3c through activation of the -Klotho co-receptor
Hung S-C, et al
When it becomes an approved option, retatrutide may be offered as a triple agonist weight loss treatment within a supervised program
NP-directed programs from $195/month
Doctors study their benefits for heart disease and sleep apnea
